Showing results (511-520 of 541) with videos related to

Sort By:
Pageof 55
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 19, 2021
The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance systemJamie Lopez Bernal, Mary A Sinnathamby, Suzanne Elgohari, et al.
The Journal of Infection|March 2, 2024
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort studyWilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
The Journal of Infection|March 2, 2024
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomesGail Hayward, Ly-Mee Yu, Paul Little, et al.
Vaccine|January 19, 2022
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in WalesStuart Bedston, Ashley Akbari, Christopher I Jarvis, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 16, 2026
Impact of structured medication reviews on prescribing in English Primary CareJames Sheppard, Paul Bateman, Cynthia Wright-Drakesmith, et al.
Lancet (London, England)|October 16, 2022
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and WalesUtkarsh Agrawal, Stuart Bedston, Colin McCowan, et al.
The Journal of Infection|August 31, 2024
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomesFd Richard Hobbs, Oghenekome A Gbinigie-Thompson, Milensu Shanyinde, et al.
BMJ Open|June 19, 2021
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher riskGail Hayward, Christopher C Butler, Ly-Mee Yu, et al.
Influenza and Other Respiratory Viruses|May 14, 2024
End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great BritainHeather J Whitaker, Naoma Willam, Simon Cottrell, et al.
Influenza and Other Respiratory Viruses|May 22, 2024
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United KingdomHeather Whitaker, Beth Findlay, Jana Zitha, et al.
Pageof 55